Registration Open for BIO Livestock Biotech SummitMar 15 2012
“With continuous advances in both biomedical and food applications, we look forward to again bringing together the world’s leading industry, academic and government leaders in the fields of science and animal agriculture.”
|
|
BIO’s 9th Annual World Congress Shows Strength of Industrial Biotech and Biofuels in Southeast United StatesMar 15 2012
We are excited to bring this conference to Orlando to highlight the industry's growth, particularly in the Southeast region.
|
|
BIO Announces Richard Lobb as Managing Director of the Council for Biotechnology InformationMar 14 2012
Lobb will lead CBI’s efforts to communicate science-based information about the benefits and safety of agricultural biotechnology and its contributions to sustainable development.
|
|
BIO Hails Senate Passage of PAHPA ReauthorizationMar 8 2012
The reauthorization of the Pandemic All-Hazards Preparedness Act and the Special Reserve Fund signify the solid commitment of government attention and funding which will allow the biotech industry to do even more to help protect our nation.
|
|
BIO Praises House Passage of the Jumpstart Our Business Startups ActMar 8 2012
House passes H.R. 3606, the Jumpstart Our Business Startups (JOBS) Act.
|
|
BIO Announces Additional Plenary Speakers for the 2012 World Congress to Address Advanced Biofuels, Renewable Chemicals and Creation of a Biobased EconomyMar 8 2012
We are excited to offer this information-packed plenary program at the 2012 World Congress where speakers will highlight how industrial biotechnology leads to innovation and new jobs while helping to build a biobased economy.
|
|
2012 BIO International Convention Super Sessions Focus on Industry OutlookMar 7 2012
Global Event for biotechnology to be held June 18-21, 2012 in Boston, MA.
|
|
BIO Applauds House Committee Vote to Repeal IPABMar 6 2012
BIO applauded the House Energy and Commerce Committee’s passage of the Medicare Decisions Accountability Act, H.R. 452, which would repeal the Independent Payment Advisory Board (IPAB) established in the health care reform law.
|
|
FAST Act Would Provide Patients with Accelerated Access to Innovative TherapiesMar 6 2012
The FAST Act will modernize the Accelerated Approval pathway to expedite the development of modern, targeted, and personalized therapies for patients suffering from serious and life-threatening diseases, while preserving the Food and Drug Administration's (FDA) robust standards for safety and effectiveness.
|
|
Biotech Leader Provides Testimony at Congressional Hearing on ‘Spurring Job Growth through Capital Formation While Protecting Investors’Mar 6 2012
OncoMed Pharmaceuticals SVP/CFO provided testimony today on behalf of BIO at a Senate Committee on Banking, Housing, and Urban Affairs
|
